Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs RenovoRx, Inc. (RNXT)

Corbus Pharmaceuticals Holdings, Inc. and RenovoRx, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and RenovoRx, Inc. are of similar size ($55.3M and $53.7M). Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −469.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 8 and RenovoRx, Inc. on 6.

Valuation

Metric CRBP RNXT Biotechnology median
P/E n/m n/m 10.60
P/S 38.44 19.79 9.40
P/B 0.58 5.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.34 n/m 0.66
EV/Sales (23.77) 17.77 9.02
Earnings yield (202.95%) (27.19%) (32.88%)
Free cash flow yield (146.45%) (22.25%) (23.13%)

Profitability

Metric CRBP RNXT Biotechnology median
Gross margin 0.00% 84.04% 68.51%
Operating margin 0.00% (489.05%) 0.00%
Net margin 0.00% (469.02%) 0.00%
Free cash flow margin 0.00% (440.38%) 0.00%
Return on equity (95.58%) (149.98%) (51.96%)
Return on assets (80.85%) (110.14%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP RNXT Biotechnology median
Revenue growth (TTM) (73.69%) — 6.76%
EPS growth (last fiscal year) (60.33%) 20.00% 29.88%
Revenue growth, 5-year CAGR (14.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP RNXT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 5.65 4.97
Net debt to EBITDA 1.90 0.56 1.01

Dividend

Metric CRBP RNXT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP RNXT Biotechnology median
Market cap 55.32m 53.70m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack